Women’s Health and Healthy Ageing
Women's Health Bulletin: January 2017, 4 (1); e60241
October 31, 2016
Article Type: Editorial
October 10, 2016
October 10, 2016
M V D. Women’s Health and Healthy Ageing,
Women Health Bull.
Copyright © 2016, Health Policy Research Center, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
There are many reasons for focusing on the importance of women’s health and healthy ageing. Recently in the Netherlands, much attention has been given to gender sensitivity as a roadmap to improve women’s health and healthy ageing.
For a long period of time, gender disparities have been addressed by medical doctors and scientists. For example, women are historically under-represented in clinical trials. Dodd et al. found that a great number of participants in clinical trials for cardiovascular diseases (CVDs) were young males below 40 years old (
1). For this reason, their advice was to to be cautious in interpreting the data extracted from clinical trials and guidelines since they can give insufficient and wrong direction for diagnosis, treatment and medication ( 1). Another example of gender disparities is about the identification of different symptoms and clinical manifestations of women compared to men. In the beginning of the 21 st century cardiologists started to recognize some specific symptoms and clinical manifestations of CVDs in women ( 2). For this reason, in 2006 the European society of cardiology (ESC) made a plea for immediate action and synergic activities in women related research, clinical trials, recommendations for education, improvement of risk stratification and setting new guidelines for diagnosis and treatment of women with CVDs ( 2). Not only CVDs but also diseases such as Migraine and Rheumatoid Arthritis have gender specific symptoms and clinical manifestations ( 3, 4). While we gain more knowledge on gender disparities, the misperception on morbidity and mortality and lack of awareness still persist. The WHO factsheet 2013 on women’s health addresses that CVD’s are undesirably still seen as a “male” issue, despite the fact that it is the number one killer of women worldwide ( 5). Due to lack of knowledge on gender disparities, prevention, aetiology, diagnostics and treatment of women diseases are not as effective as they are supposed to be. Perhaps less attention has been paid to the differences between men and women because women live longer than men and worldwide life expectancy is still increasing. For example in 2014, life expectancy of women at birth was 73.6 years compared to 54.4 years in 1960 ( 6).
Luckily, worldwide more attention is being paid to gender sensitivity and disparity. A new initiative in the Netherlands has been launched which is worth sharing. In 2012, ZonMw, medical research council that also advises the minister of health, wrote a document entitled “women are different”. This resulted in a current inauguration of a subsidiary program for “gender and health” in order to focus on women’s health and diseases. The minister of health dedicated 12 million Euro’s to support scientific research, education and implementation of programmes related to this issue. Charities are asked to finance grants for this subject as well (
7). Also the European union has set up a gender medicine (EUGenMed) project that developed a roadmap to how to stimulate gender specific research, guidelines and education programmes in Europe ( 7). Another program called European curriculum in gender medicine (EUGIM) is organized to stimulate universities to implement gender specific issues in the courses for medical doctors and nurses ( 7). Above mentioned women initiatives are crucial for improving women’s health and healthy ageing.